BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30141833)

  • 1. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical Costs Associated with Severity of Chronic Kidney Disease in Type 2 Diabetes Mellitus in Singapore.
    Lim GJ; Liu YL; Low S; Ang K; Tavintharan S; Sum CF; Lim SC
    Ann Acad Med Singap; 2020 Oct; 49(10):731-741. PubMed ID: 33283836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011.
    Ozieh MN; Dismuke CE; Lynch CP; Egede LE
    Diabetes Res Clin Pract; 2015 Jul; 109(1):185-90. PubMed ID: 25935258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang SF; Subramaniam T; Sum CF; Lim SC
    Nephrology (Carlton); 2019 Oct; 24(10):1026-1032. PubMed ID: 30565819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.
    Currie CJ; Berni ER; Berni TR; Jenkins-Jones S; Sinsakul M; Jermutus L; Ambery P; Jain M
    PLoS One; 2019; 14(8):e0221044. PubMed ID: 31461449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore.
    Low S; Lim SC; Zhang X; Zhou S; Yeoh LY; Liu YL; Tavintharan S; Sum CF
    Diabetes Res Clin Pract; 2017 Jan; 123():49-54. PubMed ID: 27923172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
    Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
    J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore.
    Zhang X; Low S; Kumari N; Wang J; Ang K; Yeo D; Yip CC; Tavintharan S; Sum CF; Lim SC
    PLoS One; 2017; 12(7):e0180949. PubMed ID: 28700742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.